Contact
searchSearch
HMP Global
Login

Advertisement

ADVERTISEMENT

News

News
For Depression Score Improvement, Lifestyle Modification Similar to Other Interventions
03/16/2023
Improvements in depression scores for patients with TRD did not significantly differ among those assigned an adjuvant online lifestyle modification program, mindfulness-based cognitive therapy, or a placebo control intervention.
Improvements in depression scores for patients with TRD did not significantly differ among those assigned an adjuvant online lifestyle modification program, mindfulness-based cognitive therapy, or a placebo control intervention.
Improvements in depression...
03/16/2023
Psych Congress Network
News
Report: Behavioral Health Visits by Telehealth Soared 45 Times During Pandemic
03/16/2023
Researchers from analytics firm Trilliant Health caution that their findings suggest the post-pandemic behavioral health market will likely increase the economic burden challenging the US healthcare system.
Researchers from analytics firm Trilliant Health caution that their findings suggest the post-pandemic behavioral health market will likely increase the economic burden challenging the US healthcare system.
Researchers from analytics firm...
03/16/2023
Behavioral Healthcare Executive

Advertisement

News
Outside Factors Contributing to Suicide Rate Differ by Sex, Study Finds
03/13/2023
This first-of-its-kind study identifies contextual circumstances that may contribute to North America’s rising suicide rates. 
This first-of-its-kind study identifies contextual circumstances that may contribute to North America’s rising suicide rates. 
This first-of-its-kind study...
03/13/2023
Psych Congress Network
News
Subtypes Indicating Success of Psychedelic Experiences Identified
03/09/2023
The 3 types are high scoring, low scoring, and positive scoring
The 3 types are high scoring, low scoring, and positive scoring
The 3 types are high scoring,...
03/09/2023
Psych Congress Network
News
Levodopa May Improve Depressive Symptoms by Reducing Brain Inflammation
03/07/2023
Levodopa, a drug that increases dopamine in the brain and is often prescribed for disorders like Parkinson disease, may improve depressive symptoms by reversing the effects of inflammation on brain reward circuits.
Levodopa, a drug that increases dopamine in the brain and is often prescribed for disorders like Parkinson disease, may improve depressive symptoms by reversing the effects of inflammation on brain reward circuits.
Levodopa, a drug that increases...
03/07/2023
Psych Congress Network

Advertisement

News
Methylphenidate Does Not Ease Overactivated Visual Perception of Children With ADHD
03/06/2023
The contextual visual perception of children with attention-deficit/hyperactivity disorder (ADHD) was not affected by a single dose of methylphenidate.
The contextual visual perception of children with attention-deficit/hyperactivity disorder (ADHD) was not affected by a single dose of methylphenidate.
The contextual visual perception...
03/06/2023
Psych Congress Network
News
Ketamine’s Effect on Brain Could Help Explain Mechanisms Behind Psychosis
03/06/2023
An investigation into how ketamine affects the brains of rats may lead to a better understanding of psychosis in people with schizophrenia.
An investigation into how ketamine affects the brains of rats may lead to a better understanding of psychosis in people with schizophrenia.
An investigation into how...
03/06/2023
Psych Congress Network
News
Patients With Comorbid ADHD, Bipolar Disorder More Susceptible to Other Disorders
03/06/2023
Patients with comorbid bipolar disorder and ADHD were found to have higher odds of other comorbid disorders, according to a new study published in the Australian & New Zealand Journal of Psychiatry.
Patients with comorbid bipolar disorder and ADHD were found to have higher odds of other comorbid disorders, according to a new study published in the Australian & New Zealand Journal of Psychiatry.
Patients with comorbid bipolar...
03/06/2023
Psych Congress Network

Advertisement

News
Pilot Study Identifies Novel Protein Biomarkers in Women Experiencing Perinatal Depression and Anxiety
03/03/2023
A pilot study has identified novel third-trimester plasma protein biomarkers that may help to indicate which women have a predisposed high risk for perinatal mood and anxiety disorders (PMADs).
A pilot study has identified novel third-trimester plasma protein biomarkers that may help to indicate which women have a predisposed high risk for perinatal mood and anxiety disorders (PMADs).
A pilot study has identified...
03/03/2023
Psych Congress Network
News
DNA Methylation Influences Gene, Protein Expression Networks in Alzheimer Disease
03/01/2023
DNA methylation has an impact on the gene and protein co-expression networks underlying Alzheimer disease, according to new study results.
DNA methylation has an impact on the gene and protein co-expression networks underlying Alzheimer disease, according to new study results.
DNA methylation has an impact on...
03/01/2023
Psych Congress Network

Advertisement

Advertisement

Advertisement

Advertisement

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Hoberg and Matthews
Clinical Pearls
Tolerability Testing in Long-Acting Injectable Prescriptions
04/03/2024
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for...
04/03/2024
Psych Congress NP Institute

Advertisement

Advertisement

Sign Up

Psych Congress Network Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use